(P-1216) Comparison of the in vivo Efficacy and Resistance Development Potential between Cefiderocol (FDC) and Ceftolozane/tazobactam (C/T) Human Simulated Exposures against Pseudomonas aeruginosa in 72 Hour Murine Thigh Infection Model

Infectious Diseases Pharmacotherapy Fellow
Hartford Hospital
Farmington, Connecticut, United States

Sanofi
Boston, Massachusetts, United States

Associate Professor
Johns Hopkins School of Medicine
Baltimore, MD, United States

Associate Professor, Director of Bacteriology
Johns Hopkins School of Medicine
Baltimore, MD, United States

Director
Hartford Hospital
Hartford, Connecticut, United States

Infectious Diseases Pharmacy Fellow
Hartford Hospital
Hartford, Connecticut, United States